Lee SC - Search Results

1

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.

Soo RA, Lim HL, Wang LZ, Lee HS, Millward MJ, Tok LT, Lee SC, Lehnert M, Goh BC. Soo RA, et al. Among authors: lee hs, lee sc. Cancer Chemother Pharmacol. 2003 Aug;52(2):153-8. doi: 10.1007/s00280-003-0637-5. Epub 2003 May 16. Cancer Chemother Pharmacol. 2003. PMID: 12750842 Clinical Trial.

2

APC I1307K and the E1317Q variants are not present in Chinese colorectal cancer patients.

Guo J, Lim R, Soo R, Leong A, Lee SC. Guo J, et al. Among authors: lee sc. Genet Med. 2004 Jul-Aug;6(4):237-8. doi: 10.1097/01.gim.0000132687.93304.c6. Genet Med. 2004. PMID: 15266213

3

Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose.

Zhao F, Loke C, Rankin SC, Guo JY, Lee HS, Wu TS, Tan T, Liu TC, Lu WL, Lim YT, Zhang Q, Goh BC, Lee SC. Zhao F, et al. Among authors: lee hs, lee sc. Clin Pharmacol Ther. 2004 Sep;76(3):210-9. doi: 10.1016/j.clpt.2004.05.005. Clin Pharmacol Ther. 2004. PMID: 15371982

4

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma.

Lee SC, Lim SG, Soo R, Hsieh WS, Guo JY, Putti T, Tao Q, Soong R, Goh BC. Lee SC, et al. Pharmacogenet Genomics. 2006 Jan;16(1):73-4. doi: 10.1097/01.fpc.0000184959.82903.02. Pharmacogenet Genomics. 2006. PMID: 16344724

5

Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug.

Tham LS, Lee HS, Wang L, Yong WP, Fan L, Ong AB, Sukri N, Soo R, Lee SC, Goh BC. Tham LS, et al. Among authors: lee hs, lee sc. Ther Drug Monit. 2006 Apr;28(2):255-61. doi: 10.1097/01.ftd.0000194497.55269.d9. Ther Drug Monit. 2006. PMID: 16628140 Clinical Trial.

6

Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients.

Xiang X, Jada SR, Li HH, Fan L, Tham LS, Wong CI, Lee SC, Lim R, Zhou QY, Goh BC, Tan EH, Chowbay B. Xiang X, et al. Among authors: lee sc. Pharmacogenet Genomics. 2006 Sep;16(9):683-91. doi: 10.1097/01.fpc.0000230420.05221.71. Pharmacogenet Genomics. 2006. PMID: 16906022 Clinical Trial.

7

Detection of epidermal growth factor receptor variations by partially denaturing HPLC.

Chin TM, Anuar D, Soo R, Salto-Tellez M, Li WQ, Ahmad B, Lee SC, Goh BC, Kawakami K, Segal A, Iacopetta B, Soong R. Chin TM, et al. Among authors: lee sc. Clin Chem. 2007 Jan;53(1):62-70. doi: 10.1373/clinchem.2006.074831. Epub 2006 Nov 16. Clin Chem. 2007. PMID: 17110474

8

Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients.

Jada SR, Lim R, Wong CI, Shu X, Lee SC, Zhou Q, Goh BC, Chowbay B. Jada SR, et al. Among authors: lee sc. Cancer Sci. 2007 Sep;98(9):1461-7. doi: 10.1111/j.1349-7006.2007.00541.x. Epub 2007 Jul 11. Cancer Sci. 2007. PMID: 17627617 Free PMC article.

9

A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers.

Yong WP, Wang LZ, Tham LS, Wong CI, Lee SC, Soo R, Sukri N, Lee HS, Goh BC. Yong WP, et al. Among authors: lee hs, lee sc. Cancer Chemother Pharmacol. 2008 Jul;62(2):243-51. doi: 10.1007/s00280-007-0598-1. Epub 2007 Oct 2. Cancer Chemother Pharmacol. 2008. PMID: 17909805 Clinical Trial.

10

Does saturable formation of gemcitabine triphosphate occur in patients?

Tham LS, Wang LZ, Soo RA, Lee HS, Lee SC, Goh BC, Holford NH. Tham LS, et al. Among authors: lee hs, lee sc. Cancer Chemother Pharmacol. 2008 Dec;63(1):55-64. doi: 10.1007/s00280-008-0707-9. Epub 2008 Feb 28. Cancer Chemother Pharmacol. 2008. PMID: 18305939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,003 results

Search Page

Filters